EUVIMEDOpdag EUVIMED
ÜbersichtsarbeitOpen access

Antiretroviral Therapy in Macrophages: Implication for HIV Eradication

Christina Gavegnano, Raymond F Schinazi

Antiviral Chemistry and Chemotherapy · 2009-10 · 20 (2) · 63-78

DOI: 10.3851/imp1374 ↗

At a glance

Übersichtsarbeit in Antiviral Chemistry and Chemotherapy, published online on 2009-10-01. Written by Christina Gavegnano and 1 co-authors. Institution: Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA. Cited 95 times so far (Crossref); 126 references. The full text is freely available in PubMed Central. Funded by: NIAID NIH HHS, NCRR NIH HHS, NIH HHS.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

HIV type-1 (HIV-1) accounts for more than 25 million deaths and nearly 40 million people are infected worldwide. A significant obstacle in clearing virus from infected individuals is latently infected viral reservoirs. Latent HIV-1 can emerge with recrudescence as a productive infection later in disease progression and could provide a source for the emergence of resistant HIV-1. It is widely recognized that macrophages represent a latently infected viral reservoir and are a significant and critical HIV-1 target cell in vivo. Macrophages can be divided into multiple subsets of macrophage-like cells, all of which are susceptible to HIV-1 infection, including dendritic cells, Langerhans cells, alveolar macrophages, mucosal macrophages and microglial cells. Current antiretroviral therapy (ART) often displays differential antiviral activity in macrophages relative to CD4 + T-lymphocytes. Significant work has been performed to establish antiviral activity of many clinically approved ART in macrophages; however, a direct link between antiviral activity and specific mechanisms responsible for these antiviral effects are incompletely understood. This review identifies many understudied areas of research, along with topics for further research in the field of HIV therapy and eradication. Discussion focuses upon the known cellular pharmacology and antiviral activity of antiretroviral agents in macrophages and its relationship to latency, chronic HIV-1 infection and therapeutic strategies to eradicate systemic HIV-1 infection.

Subjects

MeSH terms (MEDLINE)

Anti-Retroviral AgentsHIV InfectionsHumansMacrophagesMononuclear Phagocyte System

Substances

Anti-Retroviral Agents

Authors and institutions

  • Center for AIDS Research, Laboratory of Biochemical Pharmacology, Department of Pediatrics, Emory University School of Medicine, Atlanta, GA, USA.

Funding

  • NIAID NIH HHS
  • NCRR NIH HHS
  • NIH HHS

Cite

APA

Gavegnano, C., & Schinazi, R. F. (2009). Antiretroviral Therapy in Macrophages: Implication for HIV Eradication. Antiviral Chemistry and Chemotherapy, 20(2), 63-78. https://doi.org/10.3851/imp1374

Vancouver

Gavegnano C, Schinazi RF. Antiretroviral Therapy in Macrophages: Implication for HIV Eradication. Antiviral Chemistry and Chemotherapy. 2009;20(2):63-78. doi:10.3851/imp1374

BibTeX
@article{Gavegnano2009,
  author = {Gavegnano, Christina and Schinazi, Raymond F},
  title = {Antiretroviral Therapy in Macrophages: Implication for HIV Eradication},
  journal = {Antiviral Chemistry and Chemotherapy},
  year = {2009},
  volume = {20},
  number = {2},
  pages = {63--78},
  doi = {10.3851/imp1374}
}
Start for free →